Presenters
Professor and Chairman, Department of Medicine
JAVED BUTLER, MD, MPH, MBA
Course Details
The lecture is about discussion on the results of the EMPagliflozin outcomE tRial in patients With chrOnic heaRt failure with Reduced ejection fraction and Preserved ejection fraction
CPD Points: 0.75 Point
PRC Program No: PROG-2021-17858
EMPEROR Preserved: Revolutionizing Heart Failure Management Course Outline
- Discussion on the Unmet Needs in Heart Failure Treatment touching on the current available therapies in HF.
- To discuss on early evidence of heart failure benefit in SGLT-2i.
- To discuss on the trial results of EMPagliflozin outcomE tRial in patients With chrOnic heaRt failure with Preserved ejection fraction (EMPEROR-Preserved).
- To discuss on the trial results of EMPagliflozin outcomE tRial in patients With chrOnic heaRt failure with Reduced ejection fraction (EMPEROR-Reduced).